Washington [US], September 12 (ANI): Long-term blood sugar levels, known as HbA1c, can be used to accurately predict the risk of a person with type 1 diabetes having eye and kidney problems. According to research, this level should be lower than 53 mmol/mol (7%). The study tracked people for more than 30 years after they were diagnosed with type 1 diabetes.
A new study reveals that tirzepatide, a type 2 diabetes drug resulted in dramatic weight loss. The drug offers new hope for diabetic patients struggling with obesity. Diabetes drug leads to unprecedented weight loss According to a new study, tirzepatide, a drug approved for treating Type 2 diabetes is also effective for treating obesity. The […]
Washington [US], November 6 (ANI): The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.
The continuing COVID-19 pandemic remains a public health emergency worldwide, and those with underlying health conditions like diabetes remain at the top of the list for risks associated with the novel coronavirus. According to American Diabetes Association, people with diabetes face greater risks of complications when dealing with COVID-19. The risk of catching the virus […]